Acute symptomatic seizures: A clinically oriented review

Neurologist

Volumn 18, Issue 3, 2012, Pages 109-119

  Beleza, Pedro ^a  

^a Espirito Santo Saude Hospitals   (Portugal)

Author keywords

acute symptomatic seizures; causes; risk factors; treatment

Indexed keywords

ALCOHOL; AMFEBUTAMONE; ANTICONVULSIVE AGENT; CHLORPROMAZINE; CLOMIPRAMINE; CLOZAPINE; ETIRACETAM; FLUMAZENIL; GABAPENTIN; HARKOSERIDE; ILLICIT DRUG; LAMOTRIGINE; MAPROTILINE; OXCARBAZEPINE; PETHIDINE; PHENOBARBITAL; PHENYTOIN; PREGABALIN; TISSUE PLASMINOGEN ACTIVATOR; TOPIRAMATE; VALPROIC ACID; ZONISAMIDE;

ACUTE SYMPTOMATIC SEIZURE; BRAIN DISEASE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CENTRAL NERVOUS SYSTEM INFECTION; CEREBRAL SINUS THROMBOSIS; DISEASE SEVERITY; ECLAMPSIA; ELECTROLYTE DISTURBANCE; EVALUATION; HEAD INJURY; HUMAN; METABOLIC DISORDER; MORTALITY; NONHUMAN; PARANEOPLASTIC NEUROPATHY; PATHOPHYSIOLOGY; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; PREECLAMPSIA; PRIORITY JOURNAL; PROGNOSIS; PROPHYLAXIS; REVIEW; RISK FACTOR; STROKE; SUBARACHNOID HEMORRHAGE; SYMPTOMATIC EPILEPSY; TRAUMATIC BRAIN INJURY; TREATMENT PLANNING;

ACUTE DISEASE; FEMALE; HUMANS; MALE; METABOLIC DISEASES; NERVOUS SYSTEM DISEASES; PREGNANCY; PREGNANCY COMPLICATIONS; RISK FACTORS; SEIZURES; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME;

EID: 84861171553     PISSN: 10747931     EISSN: None     Source Type: Journal    
DOI: 10.1097/NRL.0b013e318251e6c3     Document Type: Review

References (171)

1. Beghi E, Carpio A, Forsgren L, et al. Recommendation for a definition of acute symptomatic seizure. Epilepsia. 2010;51: 671-675.
2. Guidelines for epidemiologic studies on epilepsy. Commission on Epidemiology and Prognosis, International League Against Epilepsy. Epilepsia. 1993;34:592-596.
3. Hauser WA, Annegers JF, Kurland LT. Prevalence of epilepsy in Rochester, Minnesota: 1940-1980. Epilepsia. 1991;32:429-445.
4. Bauer G. Seizure types and epileptic syndromes in adults. Eur Neurol. 1994;34(suppl 1):13-17. (Pubitemid 24255154)
5. Practice parameter: the neurodiagnostic evaluation of the child with a first simple febrile seizure. American Academy of Pediatrics. Provisional Committee on Quality Improvement, Subcommittee on Febrile Seizures. Pediatrics. 1996;97:769-772; discussion 773-775.
6. Scheffer IE, Berkovic SF. Generalized epilepsy with febrile seizures plus. A genetic disorder with heterogeneous clinical phenotypes. Brain. 1997;120(pt 3):479-490. (Pubitemid 27153640)
7. Engel J Jr. A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology. Epilepsia. 2001; 42:796-803. (Pubitemid 32605946)
8. Delanty N, Vaughan CJ, French JA. Medical causes of seizures. Lancet. 1998;352:383-390. (Pubitemid 28352213)
9. Hesdorffer DC, Benn EK, Cascino GD, et al. Is a first acute symptomatic seizure epilepsy? Mortality and risk for recurrent seizure. Epilepsia. 2009;50:1102-1108.
10. Fisher RS, van Emde Boas W, Blume W, et al. Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia. 2005;46:470-472. (Pubitemid 40470667)
11. Fisher RS, Leppik I. Debate: when does a seizure imply epilepsy? Epilepsia. 2008;49(suppl 9):7-12.
12. Hesdorffer DC, Logroscino G, Cascino G, et al. Risk of unprovoked seizure after acute symptomatic seizure: effect of status epilepticus. Ann Neurol. 1998;44:908-912. (Pubitemid 28558252)
13. Tardy B, Lafond P, Convers P, et al. Adult first generalized seizure: etiology, biological tests, EEG, CT scan, in an ED. Am J Emerg Med. 1995;13:1-5.
14. Dunn MJ, Breen DP, Davenport RJ, et al. Early management of adults with an uncomplicated first generalised seizure. Emerg Med J. 2005;22:237-242. (Pubitemid 40520698)
15. Krumholz A, Wiebe S, Gronseth G, et al. Practice parameter: evaluating an apparent unprovoked first seizure in adults (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2007;69:1996-2007. (Pubitemid 350145092)
16. Wiebe S, Tellez-Zenteno JF, Shapiro M. An evidence-based approach to the first seizure. Epilepsia. 2008;49(suppl 1):50-57.
17. Luders HO, Noachtar S. Atlas and Classification of Electro- encephalography. Philadelphia: Saunders; 2000.
18. Temkin NR. Antiepileptogenesis and seizure prevention trials with antiepileptic drugs: meta-analysis of controlled trials. Epilepsia. 2001;42:515-524. (Pubitemid 32322197)
19. Butzkueven H, Evans AH, Pitman A, et al. Onset seizures independently predict poor outcome after subarachnoid hemorrhage. Neurology. 2000;55:1315-1320.
20. Annegers JF, Hauser WA, Lee JR, et al. Incidence of acute symptomatic seizures in Rochester, Minnesota, 1935-1984. Epilepsia. 1995;36:327-333.
21. Loiseau J, Loiseau P, Guyot M, et al. Survey of seizure disorders in the French southwest. I. Incidence of epileptic syndromes. Epilepsia. 1990;31:391-396. (Pubitemid 20226665)
22. Costello DJ, Cole AJ. Treatment of acute seizures and status epilepticus. J Intensive Care Med. 2007;22:319-347. (Pubitemid 350132176)
23. Faught E, Peters D, Bartolucci A, et al. Seizures after primary intracerebral hemorrhage. Neurology. 1989;39:1089-1093. (Pubitemid 19217479)
24. Weisberg LA, Shamsnia M, Elliott D. Seizures caused by nontraumatic parenchymal brain hemorrhages. Neurology. 1991; 41:1197-1199.
25. Bladin CF, Alexandrov AV, Bellavance A, et al. Seizures after stroke: a prospective multicenter study. Arch Neurol. 2000; 57:1617-1622.
26. Ferro JM, Canhao P, Stam J, et al. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke. 2004;35:664-670. (Pubitemid 38280838)
27. Ferro JM, Correia M, Rosas MJ, et al. Seizures in cerebral vein and dural sinus thrombosis. Cerebrovasc Dis. 2003;15:78-83. (Pubitemid 36131902)
28. Kim MA, Park KM, Kim SE, et al. Acute symptomatic seizures in CNS infection. Eur J Neurol. 2008;15:38-41.
29. Bruns J Jr, Hauser WA. The epidemiology of traumatic brain injury: a review. Epilepsia. 2003;44(suppl 10):2-10. (Pubitemid 37280386)
30. Starkey IR, Lawson AA. Psychiatric aspects of acute poisoning with tricyclic and related antidepressants\-a ten-year review. Scott Med J. 1980;25:303-308. (Pubitemid 11222877)
31. Devinsky O, Honigfeld G, Patin J. Clozapine-related seizures. Neurology. 1991;41:369-371.
32. Pascual-Leone A, Dhuna A, Altafullah I, et al. Cocaine-induced seizures. Neurology. 1990;40(pt 1):404-407. (Pubitemid 20117518)
33. Dhuna A, Pascual-Leone A, Langendorf F, et al. Epileptogenic properties of cocaine in humans. Neurotoxicology. 1991;12:621-626.
34. Alldredge BK, Lowenstein DH, Simon RP. Seizures associated with recreational drug abuse. Neurology. 1989;39:1037-1039. (Pubitemid 19217470)
35. Boggs JG. Seizures in medically complex patients. Epilepsia. 1997;38(suppl 4):S55-S59. (Pubitemid 27318325)
36. Whang R, Hampton EM, Whang DD. Magnesium homeostasis and clinical disorders of magnesium deficiency. Ann Pharmac-other. 1994;28:220-226. (Pubitemid 24073465)
37. Gao X, Wee AS, Nick TG. Effect of keto-acidosis on seizure occurrence in diabetic patients. J Miss State Med Assoc. 2005;46:131-133.
38. Lamy C, Domigo V, Semah F, et al. Early and late seizures after cryptogenic ischemic stroke in young adults. Neurology. 2003;60:400-404. (Pubitemid 36188233)
39. Beghi E, D'Alessandro R, Beretta S, et al. Incidence and predictors of acute symptomatic seizures after stroke. Neurology. 2011;77:1785-1793.
40. Sung CY, Chu NS. Epileptic seizures in thrombotic stroke. J Neurol. 1990;237:166-170.
41. Kelly KM. Animal modeling of poststroke seizures and epilepsy: 5-year update. Epilepsy Curr. 2007;7:159-162.
42. Labovitz DL, Hauser WA, Sacco RL. Prevalence and predictors of early seizure and status epilepticus after first stroke. Neurology. 2001;57:200-206. (Pubitemid 32667352)
43. Hijdra A, Brouwers PJ, Vermeulen M, et al. Grading the amount of blood on computed tomograms after subarachnoid hemorrhage. Stroke. 1990;21:1156-1161. (Pubitemid 20255410)
44. Arboix A, Garcia-Eroles L, Massons JB, et al. Predictive factors of early seizures after acute cerebrovascular disease. Stroke. 1997;28:1590-1594. (Pubitemid 27349687)
45. Qureshi AI, Sung GY, Suri MA, et al. Prognostic value and determinants of ultraearly angiographic vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurgery. 1999;44: 967-973; discussion 973-964.
46. Noachtar S, Peters AS. Semiology of epileptic seizures: a critical review. Epilepsy Behav. 2009;15:2-9.
47. Gilmore E, Choi HA, Hirsch LJ, et al. Seizures and CNS hemorrhage: spontaneous intracerebral and aneurysmal subar-achnoid hemorrhage. Neurologist. 2010;16:165-175.
48. Bederson JB, Connolly ES, Batjer HH, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke. 2009;40:994-1025.
49. Naidech AM, Kreiter KT, Janjua N, et al. Phenytoin exposure is associated with functional and cognitive disability after sub-arachnoid hemorrhage. Stroke. 2005;36:583-587. (Pubitemid 40352567)
50. Hasan D, Schonck RS, Avezaat CJ, et al. Epileptic seizures after subarachnoid hemorrhage. Ann Neurol. 1993;33:286-291. (Pubitemid 23081160)
51. Herman ST. Epilepsy after brain insult: targeting epileptogenesis. Neurology. 2002;59(suppl 5):S21-S26. (Pubitemid 35285971)
52. De Herdt V, Dumont F, Henon H, et al. Early seizures in intracerebral hemorrhage: incidence, associated factors, and outcome. Neurology. 2011;77:1794-1800.
53. Kucukkaya B, Aker R, Yuksel M, et al. Low dose MK-801 protects against iron-induced oxidative changes in a rat model of focal epilepsy. Brain Res. 1998;788:133-136. (Pubitemid 28202153)
54. Broderick J, Connolly S, Feldmann E, et al. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/ American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Stroke. 2007;38:2001-2023.
55. Passero S, Rocchi R, Rossi S, et al. Seizures after spontaneous supratentorial intracerebral hemorrhage. Epilepsia. 2002;43: 1175-1180. (Pubitemid 35176125)
56. Kilpatrick CJ, Davis SM, Tress BM, et al. Epileptic seizures in acute stroke. Arch Neurol. 1990;47:157-160. (Pubitemid 20058111)
57. Schulz UG, Rothwell PM. Transient ischaemic attacks mimicking focal motor seizures. Postgrad Med J. 2002;78:246-247. (Pubitemid 34293329)
58. Noachtar S. Seizure semiology. In: Lüders HO, ed. Epilepsy: Comprehensive Review and Case Discussions. London: Martin Dunitz Publishers; 2001:127-140.
59. Giroud M, Dumas R. Role of associated cortical lesions in motor partial seizures and lenticulostriate infarcts. Epilepsia. 1995;36: 465-470.
60. Kammersgaard LP, Olsen TS. Poststroke epilepsy in the Copenhagen stroke study: incidence and predictors. J Stroke Cerebrovasc Dis. 2005;14:210-214. (Pubitemid 41318039)
61. Sun DA, Sombati S, DeLorenzo RJ. Glutamate injury-induced epileptogenesis in hippocampal neurons: an in vitro model of stroke-induced "epilepsy". Stroke. 2001;32:2344-2350. (Pubitemid 32954807)
62. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis. 2008;25: 457-507.
63. De Reuck J, De Groote L, Van Maele G. Single seizure and epilepsy in patients with a cerebral territorial infarct. J Neurol Sci. 2008;271:127-130.
64. Ryvlin P, Montavont A, Nighoghossian N. Optimizing therapy of seizures in stroke patients. Neurology. 2006;67(suppl 4):S3-S9. (Pubitemid 44967989)
65. Zemke D, Farooq MU, Gupta R, et al. The effect of anticonvulsant drugs on the fibrinolytic activity of tissue plasminogen activator. Cerebrovasc Dis. 2008;25:107-110. (Pubitemid 351280383)
66. Rodan LH, Aviv RI, Sahlas DJ, et al. Seizures during stroke thrombolysis heralding dramatic neurologic recovery. Neurology. 2006;67:2048-2049. (Pubitemid 44967389)
67. Fleitman JS, Bruni J, Perrin JH, et al. Albumin-binding interactions of sodium valproate. J Clin Pharmacol. 1980;20: 514-517. (Pubitemid 11199654)
68. Glauser T, Ben-Menachem E, Bourgeois B, et al. ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia. 2006;47:1094-1120. (Pubitemid 44086745)
69. Alvarez-Sabin J, Montaner J, Padro L, et al. Gabapentin in late-onset poststroke seizures. Neurology. 2002;59:1991-1993. (Pubitemid 36076581)
70. Reith J, Jorgensen HS, Nakayama H, et al. Seizures in acute stroke: predictors and prognostic significance. The Copenhagen Stroke Study. Stroke. 1997;28:1585-1589. (Pubitemid 27349686)
71. Williams AJ, Tortella FC. Neuroprotective effects of the sodium channel blocker RS100642 and attenuation of ischemia-induced brain seizures in the rat. Brain Res. 2002;932:45-55. (Pubitemid 34241593)
72. Ferro JM, Canhao P, Bousser MG, et al. Early seizures in cerebral vein and dural sinus thrombosis: risk factors and role of antiepileptics. Stroke. 2008;39:1152-1158. (Pubitemid 351440684)
73. Kwan J, Guenther A. Antiepileptic drugs for the primary and secondary prevention of seizures after intracranial venous thrombosis. Cochrane Database Syst Rev. 2006;3:CD005501.
74. Annegers JF, Grabow JD, Groover RV, et al. Seizures after head trauma: a population study. Neurology. 1980;30(pt 1):683-689. (Pubitemid 10033661)
75. Temkin NR, Dikmen SS, Wilensky AJ, et al. A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures. N Engl J Med. 1990;323:497-502. (Pubitemid 20260049)
76. Chang BS, Lowenstein DH. Practice parameter: antiepileptic drug prophylaxis in severe traumatic brain injury: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2003;60:10-16. (Pubitemid 36070636)
77. Beghi E. Overview of studies to prevent posttraumatic epilepsy. Epilepsia. 2003;44(suppl 10):21-26. (Pubitemid 37280389)
78. Glotzner FL, Haubitz I, Miltner F, et al. Seizure prevention using carbamazepine following severe brain injuries. Neurochirurgia (Stuttg). 1983;26:66-79. (Pubitemid 13099196)
79. Temkin NR, Dikmen SS, Anderson GD, et al. Valproate therapy for prevention of posttraumatic seizures: a randomized trial. J Neurosurg. 1999;91:593-600. (Pubitemid 30133456)
80. Annegers JF, Hauser WA, Coan SP, et al. A population-based study of seizures after traumatic brain injuries. N Engl J Med. 1998;338:20-24. (Pubitemid 28040171)
81. Annegers JF, Hauser WA, Beghi E, et al. The risk of unprovoked seizures after encephalitis and meningitis. Neurology. 1988;38: 1407-1410.
82. Diaz-Arrastia R, Agostini MA, Frol AB, et al. Neurophysiologic and neuroradiologic features of intractable epilepsy after traumatic brain injury in adults. Arch Neurol. 2000;57: 1611-1616.
83. Temkin NR. Preventing and treating posttraumatic seizures: the human experience. Epilepsia. 2009;50(suppl 2):10-13.
84. Cornejo BJ, Mesches MH, Coultrap S, et al. A single episode of neonatal seizures permanently alters glutamatergic synapses. Ann Neurol. 2007;61:411-426. (Pubitemid 46878769)
85. Rakhade SN, Zhou C, Aujla PK, et al. Early alterations of AMPA receptors mediate synaptic potentiation induced by neonatal seizures. J Neurosci. 2008;28:7979-7990.
86. McNamara JO, Huang YZ, Leonard AS. Molecular signaling mechanisms underlying epileptogenesis. Sci STKE. 2006; 2006:re12.
87. Vezzani A, Granata T. Brain inflammation in epilepsy: experimental and clinical evidence. Epilepsia. 2005;46: 1724-1743. (Pubitemid 44921957)
88. Scharfman HE. The neurobiology of epilepsy. Curr Neurol Neurosci Rep. 2007;7:348-354. (Pubitemid 47098457)
89. Dudek FE, Sutula TP. Epileptogenesis in the dentate gyrus: a critical perspective. Prog Brain Res. 2007;163:755-773. (Pubitemid 47321462)
90. Pitkanen A, Immonen RJ, Grohn OH, et al. From traumatic brain injury to posttraumatic epilepsy: what animal models tell us about the process and treatment options. Epilepsia. 2009; 50(suppl 2):21-29.
91. Jensen FE. Introduction. Posttraumatic epilepsy: treatable epileptogenesis. Epilepsia. 2009;50(suppl 2):1-3.
92. Misra UK, Tan CT, Kalita J. Viral encephalitis and epilepsy. Epilepsia. 2008;49(suppl 6):13-18.
93. Beghi E, Carpio A, Forsgren L, et al. Recommendation for a definition of acute symptomatic seizure. Epilepsia. 2010;51: 671-675.
94. Nash TE, Del Brutto OH, Butman JA, et al. Calcific neuro-cysticercosis and epileptogenesis. Neurology. 2004;62:1934-1938.
95. Wang S, Cheng Q, Malik S, et al. Interleukin-1beta inhibits gamma-aminobutyric acid type A (GABA(A)) receptor current in cultured hippocampal neurons. J Pharmacol Exp Ther. 2000; 292:497-504. (Pubitemid 30067411)
96. Carpio A, Hauser WA. Prognosis for seizure recurrence in patients with newly diagnosed neurocysticercosis. Neurology. 2002;59:1730-1734. (Pubitemid 35424454)
97. Medina MT, Rosas E, Rubio-Donnadieu F, et al. Neuro-cysticercosis as the main cause of late-onset epilepsy in Mexico. Arch Intern Med. 1990;150:325-327. (Pubitemid 20063039)
98. Trinka E, Dubeau F, Andermann F, et al. Successful epilepsy surgery in catastrophic postencephalitic epilepsy. Neurology. 2000;54:2170-2173. (Pubitemid 30397225)
99. Marks DA, Kim J, Spencer DD, et al. Characteristics of intractable seizures following meningitis and encephalitis. Neurology. 1992;42:1513-1518.
100. O'Brien TJ, Moses H, Cambier D, et al. Age of meningitis or encephalitis is independently predictive of outcome from anterior temporal lobectomy. Neurology. 2002;58:104-109. (Pubitemid 34041945)
101. Schlitt M, Bucher AP, Quindlen EA, et al. Nonfulminant herpes simplex encephalitis as a cause for mesial temporal sclerosis. Med Hypotheses. 1990;33:177-179. (Pubitemid 20383058)
102. Theodore WH, Epstein L, Gaillard WD, et al. Human herpes virus 6B: a possible role in epilepsy? Epilepsia. 2008;49: 1828-1837.
103. Gutnick MJ, Van Duijn H, Citri N. Relative convulsant potencies of structural analogues of penicillin. Brain Res. 1976;114:139-143.
104. Fujimoto M, Munakata M, Akaike N. Dual mechanisms of GABAA response inhibition by beta-lactam antibiotics in the pyramidal neurones of the rat cerebral cortex. Br J Pharmacol. 1995;116:3014-3020.
105. Morrow LE, Wear RE, Schuller D, et al. Acute isoniazid toxicity and the need for adequate pyridoxine supplies. Pharmacotherapy. 2006;26:1529-1532. (Pubitemid 44521739)
106. Montgomery SA. Antidepressants and seizures: emphasis on newer agents and clinical implications. Int J Clin Pract. 2005;59:1435-1440. (Pubitemid 43922631)
107. Brust JC. Seizures and substance abuse: treatment considerations. Neurology. 2006;67(suppl 4):S45-S48. (Pubitemid 44967997)
108. Cubala WJ, Landowski J. Seizure following sudden zolpidem withdrawal. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31:539-540. (Pubitemid 46209407)
109. Fialip J, Aumaitre O, Eschalier A, et al. Benzodiazepine withdrawal seizures: analysis of 48 case reports. Clin Neuro-pharmacol. 1987;10:538-544. (Pubitemid 17167171)
110. Fraser HF, Wikler A, Essig CF, et al. Degree of physical dependence induced by secobarbital or pentobarbital. J Am Med Assoc. 1958;166:126-129.
111. Sellers EM. Alcohol, barbiturate and benzodiazepine withdrawal syndromes: clinical management. CMAJ. 1988;139:113-120.
112. Martinez-Cano H, Vela-Bueno A, de Iceta M, et al. Benzodia-zepine withdrawal syndrome seizures. Pharmacopsychiatry. 1995;28:257-262.
113. Denis C, Fatseas M, Lavie E, et al. Pharmacological interventions for benzodiazepine mono-dependence management in outpatient settings. Cochrane Database Syst Rev. 2006;3:CD005194.
114. Wijdicks EF, Sharbrough FW. New-onset seizures in critically ill patients. Neurology. 1993;43:1042-1044. (Pubitemid 23150585)
115. Earnest MP, Yarnell PR. Seizure admissions to a city hospital: the role of alcohol. Epilepsia. 1976;17:387-393. (Pubitemid 8025560)
116. Rathlev NK, Ulrich A, Shieh TC, et al. Etiology and weekly occurrence of alcohol-related seizures. Acad Emerg Med. 2002;9:824-828. (Pubitemid 34856300)
117. Sand T, Brathen G, Michler R, et al. Clinical utility of EEG in alcohol-related seizures. Acta Neurol Scand. 2002;105:18-24. (Pubitemid 34188265)
118. McKeon A, Frye MA, Delanty N. The alcohol withdrawal syndrome. J Neurol Neurosurg Psychiatry. 2008;79:854-862.
119. Faingold CL, Riaz A. Ethanol withdrawal induces increased firing in inferior colliculus neurons associated with audiogenic seizure susceptibility. Exp Neurol. 1995;132:91-98.
120. Feng HJ, Yang L, Faingold CL. Role of the amygdala in ethanol withdrawal seizures. Brain Res. 2007;1141:65-73. (Pubitemid 46365645)
121. Hillbom M, Pieninkeroinen I, Leone M. Seizures in alcohol-dependent patients: epidemiology, pathophysiology and management. CNS Drugs. 2003;17:1013-1030. (Pubitemid 37463820)
122. Rathlev NK, Ulrich A. Clinical characteristics as predictors of recurrent alcohol-related seizures. Acad Emerg Med. 2000; 7:886-891. (Pubitemid 30626284)
123. Brathen G, Ben-Menachem E, Brodtkorb E, et al. EFNS guideline on the diagnosis and management of alcohol-related seizures: report of an EFNS task force. Eur J Neurol. 2005;12:575-581. (Pubitemid 41117281)
124. Hughes JR. Alcohol withdrawal seizures. Epilepsy Behav. 2009;15:92-97.
125. Alcohol withdrawal syndrome: how to predict, prevent, diagnose and treat it. Prescrire Int. 2007;16:24-31.
126. Abraham HD, Duffy FH. EEG coherence in post-LSD visual hallucinations. Psychiatry Res. 2001;107:151-163. (Pubitemid 32868800)
127. Fisher DD, Ungerleider JT. Grand mal seizures following ingestion of LSD. Calif Med. 1967;106:210-211.
128. Brust J. Seizures and illicit drug use. In: Delanty N, ed. Seizures: medical causes and management. Totowa, NJ: Humana Press, Inc; 2001:183-192.
129. Ng SK, Brust JC, Hauser WA, et al. Illicit drug use and the risk of new-onset seizures. Am J Epidemiol. 1990;132:47-57. (Pubitemid 20203302)
130. Riggs JE. Neurologic manifestations of electrolyte disturbances. Neurol Clin. 2002;20:227-239. vii.
131. Kahn A, Blum D, Casimir G, et al. Controlled fall in natremia in hypertonic dehydration: possible avoidance of rehydration seizures. Eur J Pediatr. 1981;135:293-296. (Pubitemid 11137456)
132. Kunze K. Metabolic encephalopathies. J Neurol. 2002;249: 1150-1159. (Pubitemid 35025087)
133. Krumholz A, Stern BJ, Weiss HD. Outcome from coma after cardiopulmonary resuscitation: relation to seizures and myoclo-nus. Neurology. 1988;38:401-405. (Pubitemid 18083676)
134. Wijdicks EF, Parisi JE, Sharbrough FW. Prognostic value of myoclonus status in comatose survivors of cardiac arrest. Ann Neurol. 1994;35:239-243. (Pubitemid 24050163)
135. Zandbergen EG, Hijdra A, Koelman JH, et al. Prediction of poor outcome within the first 3 days of postanoxic coma. Neurology. 2006;66:62-68. (Pubitemid 43739593)
136. Wijdicks EF, Hijdra A, Young GB, et al. Practice parameter: prediction of outcome in comatose survivors after cardiopulmo-nary resuscitation (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2006;67:203-210. (Pubitemid 44305400)
137. Morris HR, Howard RS, Brown P. Early myoclonic status and outcome after cardiorespiratory arrest. J Neurol Neurosurg Psychiatry. 1998;64:267-268. (Pubitemid 28159816)
138. Arnoldus EP, Lammers GJ. Postanoxic coma: good recovery despite myoclonus status. Ann Neurol. 1995;38:697-698.
139. Werhahn KJ, Brown P, Thompson PD, et al. The clinical features and prognosis of chronic posthypoxic myoclonus. Mov Disord. 1997;12:216-220. (Pubitemid 27152026)
140. Harper SJ, Wilkes RG. Posthypoxic myoclonus (the Lance-Adams syndrome) in the intensive care unit. Anaesthesia. 1991;46:199-201.
141. Bass E. Cardiopulmonary arrest. Pathophysiology and neurologic complications. Ann Intern Med. 1985;103(pt 1):920-927.
142. Rossetti AO, Oddo M, Liaudet L, et al. Predictors of awakening from postanoxic status epilepticus after therapeutic hypothermia. Neurology. 2009;72:744-749.
143. Caviness JN, Brown P. Myoclonus: current concepts and recent advances. Lancet Neurol. 2004;3:598-607. (Pubitemid 39221926)
144. Young GB, Jordan KG, Doig GS. An assessment of non-convulsive seizures in the intensive care unit using continuous EEG monitoring: an investigation of variables associated with mortality. Neurology. 1996;47:83-89. (Pubitemid 26243864)
145. Kaplan PW. EEG criteria for nonconvulsive status epilepticus. Epilepsia. 2007;48(suppl 8):39-41. (Pubitemid 350045521)
146. Bauer G, Trinka E. Nonconvulsive status epilepticus and coma. Epilepsia. 2010;51:177-190.
147. Brenner RP. Is it status? Epilepsia. 2002;43(suppl 3):103-113. (Pubitemid 34633703)
148. Waterhouse EJ, Vaughan JK, Barnes TY, et al. Synergistic effect of status epilepticus and ischemic brain injury on mortality. Epilepsy Res. 1998;29:175-183. (Pubitemid 28137596)
149. Drislane FW, Schomer DL. Clinical implications of generalized electrographic status epilepticus. Epilepsy Res. 1994;19:111-121. (Pubitemid 24317086)
150. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005;365:785-799. (Pubitemid 40311367)
151. Sibai BM, El-Nazer A, Gonzalez-Ruiz A. Severe preeclampsia-eclampsia in young primigravid women: subsequent pregnancy outcome and remote prognosis. Am J Obstet Gynecol. 1986;155: 1011-1016. (Pubitemid 17176667)
152. Shah AK, Rajamani K, Whitty JE. Eclampsia: a neurological perspective. J Neurol Sci. 2008;271:158-167.
153. Douglas KA, Redman CW. Eclampsia in the United Kingdom. BMJ. 1994;309:1395-1400. (Pubitemid 24351401)
154. Loureiro R, Leite CC, Kahhale S, et al. Diffusion imaging may predict reversible brain lesions in eclampsia and severe preeclampsia: initial experience. Am J Obstet Gynecol. 2003; 189:1350-1355. (Pubitemid 37542171)
155. Wasseff S. Mechanisms of convulsions in eclampsia. Med Hypotheses. 2009;72:49-51.
156. Altman D, Carroli G, Duley L, et al. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet. 2002;359:1877-1890. (Pubitemid 34615765)
157. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet. 1995;345:1455-1463.
158. Euser AG, Cipolla MJ. Magnesium sulfate for the treatment of eclampsia: a brief review. Stroke. 2009;40:1169-1175.
159. Wu CS, Sun Y, Vestergaard M, et al. Preeclampsia and risk for epilepsy in offspring. Pediatrics. 2008;122:1072-1078.
160. Lawn N, Laich E, Ho S, et al. Eclampsia, hippocampal sclerosis, and temporal lobe epilepsy: accident or association? Neurology. 2004;62:1352-1356. (Pubitemid 38526048)
161. Lee VH, Wijdicks EF, Manno EM, et al. Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Arch Neu-rol. 2008;65:205-210. (Pubitemid 351240781)
162. Bakshi R, Bates VE, Mechtler LL, et al. Occipital lobe seizures as the major clinical manifestation of reversible posterior leukoencephalopathy syndrome: magnetic resonance imaging findings. Epilepsia. 1998;39:295-299. (Pubitemid 28141310)
163. Schwartz RB. A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1996;334:1743; author reply 1746.
164. Solinas C, Briellmann RS, Harvey AS, et al. Hypertensive encephalopathy: antecedent to hippocampal sclerosis and temporal lobe epilepsy? Neurology. 2003;60:1534-1536. (Pubitemid 36554822)
165. Bien CG, Elger CE. Limbic encephalitis: a cause of temporal lobe epilepsy with onset in adult life. Epilepsy Behav. 2007;10:529-538. (Pubitemid 46768031)
166. Tuzun E, Dalmau J. Limbic encephalitis and variants: classification, diagnosis and treatment. Neurologist. 2007;13:261-271. (Pubitemid 47396312)
167. Vincent A, Buckley C, Schott JM, et al. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain. 2004;127:701-712. (Pubitemid 38295483)
168. Ances BM, Vitaliani R, Taylor RA, et al. Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates. Brain. 2005;128:1764-1777. (Pubitemid 41373648)
169. Gultekin SH, Rosenfeld MR, Voltz R, et al. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain. 2000;123(Pt 7): 1481-1494. (Pubitemid 30420947)
170. Urbach H, Soeder BM, Jeub M, et al. Serial MRI of limbic encephalitis. Neuroradiology. 2006;48:380-386. (Pubitemid 43923159)
171. Hauser WA, Annegers JF, Kurland LT. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984. Epilepsia. 1993;34:453-468. (Pubitemid 23184580)